| Structure |
Chemical Name |
CAS |
MF |
 |
Keto Bisoprolol |
864544-37-6 |
C18H29NO5 |
 |
Olopatadine Carbaldehyde DISCONTINUED |
1376615-97-2 |
C21H23NO2 |
 |
5-Chloro-1-methyl-4-nitroimidazole |
|
C4H4ClN3O2 |
 |
Nisoldipine Related Compound II |
|
|
 |
5-Chloro-N1-Methylbenzene-1,2-diaMine |
84859-27-8 |
C7H9ClN2 |
 |
(1'S,3'S,4'S)-Entecavir IsoMer |
1367369-80-9 |
C12H15N5O3 |
 |
Iso Ganciclovir |
86357-09-7 |
C9H13N5O4 |
![(1S,3R)-1-Benzo[1,3]dioxol-5-yl-2-(2-chloro-acetyl)-2,3,4,9-tetrahydro-1H-b-carboline-3-carboxylic Acid Methyl Ester](/CAS/GIF/629652-40-0.gif) |
(1S,3R)-1-Benzo[1,3]dioxol-5-yl-2-(2-chloro-acetyl)-2,3,4,9-tetrahydro-1H-b-carboline-3-carboxylic Acid Methyl Ester |
629652-40-0 |
C22H19ClN2O5 |
![2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide](/CAS/20180906/GIF/503155-67-7.gif) |
2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide |
503155-67-7 |
C46H45N7O2 |
 |
O-De(3-fluorobenzyl) Lapatinib |
1268997-70-1 |
C22H21ClN4O4S |
![5-Des[2-(tert-butylaMino)] BaMbuterol-5-ethylenediol](/CAS/GIF/112935-92-9.gif) |
5-Des[2-(tert-butylaMino)] BaMbuterol-5-ethylenediol |
112935-92-9 |
C14H20N2O6 |
 |
Desloratadine Epoxide |
1346604-23-6 |
C19H19ClN2O |
 |
Menaquinone 4 2,3-Epoxide |
72908-86-2 |
C31H40O3 |
 |
D-Phenylalanyl Nateglinide |
944746-48-9 |
C28H36N2O4 |
 |
Felodipine 3,5-DiMethyl Ester |
91189-59-2 |
C17H17Cl2NO4 |
 |
Moxifloxacin Methyl Ester |
721970-35-0 |
C22H26FN3O4 |
 |
Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride) |
873310-31-7 |
C17H22ClNO |
![Dofetilide Related Compound A (25 mg) (N-[4-(2-(2-[4-(methanesulfonamido)phenoxy]ethyl)amino)phenyl]methanesulfonamide)](/CAS/20180808/GIF/176447-94-2.gif) |
Dofetilide Related Compound A (25 mg) (N-[4-(2-(2-[4-(methanesulfonamido)phenoxy]ethyl)amino)phenyl]methanesulfonamide) |
176447-94-2 |
C18H25N3O5S2 |
![Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)](/CAS/20150408/GIF/139264-69-0.gif) |
Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol) |
139264-69-0 |
C15H23N3O |
 |
1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE |
384338-23-2 |
C14H22N2 |
 |
(R,Z)-2-((R)-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)(carboxy)Methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
178422-39-4 |
C14H15N5O6S2 |
 |
Acyclovir IMpurity C |
91702-61-3 |
C8H11N5O3 |
 |
Nicergoline-5-Chloro Analogue |
38536-28-6 |
C24H26ClN3O3 |
 |
1-(3-aMino-5-(benzyloxy)-2-hydroxyphenyl)ethanone |
861841-90-9 |
C15H15NO3 |
![(2RS)-2-Hydroxy-2-[4-(2-Methylpropyl)phenyl]propanoic Acid](/CAS/20130318/GIF/CB12605011.gif) |
(2RS)-2-Hydroxy-2-[4-(2-Methylpropyl)phenyl]propanoic Acid |
|
C13H18O3 |
![(3RS)-1,3-Bis[4-(2-Methylpropyl) phenyl]butan-1-one](/CAS/20130318/GIF/CB12605026.gif) |
(3RS)-1,3-Bis[4-(2-Methylpropyl) phenyl]butan-1-one |
|
C24H32O |
![2-[4-(2-Methylpropyl)phenyl] ethanol](/CAS/20130318/GIF/CB12605071.gif) |
2-[4-(2-Methylpropyl)phenyl] ethanol |
2143535-25-3 |
C24H32O |
![1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide](/CAS/GIF/1292904-74-5.gif) |
1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide |
1292904-74-5 |
C20H23BrFN3O4 |
 |
IMp. K (EP) |
40610-41-1 |
C13H17NO3 |
![(Z)-Methyl 3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate](/CAS/20130318/GIF/CB12611218.gif) |
(Z)-Methyl 3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate |
1499167-72-4 |
C23H20N4O4 |
 |
4-(4-fluorobenzoyl)-3-(hydroxyMethyl)benzonitrile |
260371-16-2 |
C15H10FNO2 |
 |
ATV-FX1 sodiuM salt |
1315629-79-8 |
C33H34FN2NaO7 |
 |
Montelukast Impurity H |
851755-56-1 |
C34H32ClNO4S |
 |
SalMeterol EP IMpurity F |
1391054-40-2 |
C25H37NO3 |
![[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-7-yl]](/CAS/20130318/GIF/CB12621453.gif) |
[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-7-yl] |
1391054-73-1 |
C28H27NO4S |
![(R)-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]Methyl]-1-naphthaleneMethaneaMine Hydrochloride](/CAS/GIF/1229225-42-6.gif) |
(R)-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]Methyl]-1-naphthaleneMethaneaMine Hydrochloride |
1229225-42-6 |
C20H19ClF3N |
 |
3(S)-Hydroperoxy Simvastatin |
1092716-44-3 |
C25H38O7 |
 |
2(RS)-4-Methyl-1-(3-Methylpyridin-2-yl)-2-phenylpiperazine |
191546-94-8 |
C17H21N3 |
![ForMaMide, N-[5-(2R)-oxiranyl-2-(phenylMethoxy)phenyl]-](/CAS/GIF/201677-57-8.gif) |
ForMaMide, N-[5-(2R)-oxiranyl-2-(phenylMethoxy)phenyl]- |
201677-57-8 |
C16H15NO3 |
 |
2-(MethylcarbaMoyl)benzoic acid |
6843-36-3 |
C9H9NO3 |
 |
1-(4-(2-Methoxyethyl)phenoxy)-3-(oxiran-2-ylMethoxy)propan-2-ol |
1416440-64-6 |
C15H22O5 |
 |
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine |
1354621-59-2 |
C14H22N2 |
![1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester](/CAS/GIF/1403474-70-3.gif) |
1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester |
1403474-70-3 |
C27H24N4O5 |
![6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one](/CAS/GIF/571189-64-5.gif) |
6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
571189-64-5 |
C15H18N4O2 |
 |
Apixaban-13C-D3 |
1261393-15-0 |
C2413CH22D3N5O4 |
![IMp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]-CarbaMate](/) |
IMp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]-CarbaMate |
|
|
![IMp. C (EP): Methyl-2-[4-[2-[(4-Chlorobenzoyl)aMino]ethyl]phenoxy]-2-Methylpropanoate](/) |
IMp. C (EP): Methyl-2-[4-[2-[(4-Chlorobenzoyl)aMino]ethyl]phenoxy]-2-Methylpropanoate |
|
|
 |
5-PyriMidinecarboxylic acid, 4-(4-fluorophenyl)-1,2-dihydro-6-(1-Methylethyl)-2-oxo-, Methyl ester |
488798-37-4 |
C15H15FN2O3 |
 |
AgoMelatine DiMer Urea |
185421-27-6 |
C27H28N2O3 |
 |
AgoMelatine DiMer Urea |
185421-27-6 |
C27H28N2O3 |
 |
Isotachysterol3 |
22350-43-2 |
C27H44O |
 |
Nitrendipine Propyl Ester |
225785-54-6 |
C19H22N2O6 |
 |
O-DesMethyl Urapidil |
91453-03-1 |
C19H27N5O3 |
 |
(1R,3R,4R)-Entecavir |
1367369-76-3 |
C12H15N5O3 |
![5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate](/CAS/20150408/GIF/1056459-37-0.gif) |
5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
1056459-37-0 |
C20H21ClFNO3S |
 |
(2S,3R)-2-((S)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-3-(4-fluorophenyl)Morpholine |
327623-37-0 |
C20H18F7NO2 |
 |
Linagliptin iMpurity |
2140263-92-7 |
C25H28N8O2 |
![1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxaMide](/CAS/20150408/GIF/256376-62-2.gif) |
1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxaMide |
256376-62-2 |
C14H11FN4O |
 |
Alogliptin iMpurity |
60271-06-9 |
C7H10N2O3 |
 |
Alogliptin iMpurity |
60271-06-9 |
C7H10N2O3 |
 |
cefaclor iMpurity H |
|
C4H6N4O3S2 |
 |
Tadalafil iMpurity E |
|
|
 |
3,3',5-TRIIODOTHYROPROPIONIC ACID |
51-26-3 |
C15H11I3O4 |
 |
Cytidine,N-benzoyl-2^-C-Methyl-,3^,5^-dibenzoate(9CI) |
863329-64-0 |
C31H27N3O8 |
 |
(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-Methyl-2,6-dioxo-1,2,3,6-tetrahydropyriMidin-4-yl)aMino)piperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile |
1268836-55-0 |
C31H30N8O4 |
 |
(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-Methyl-2,6-dioxo-1,2,3,6-tetrahydropyriMidin-4-yl)aMino)piperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile |
1268836-55-0 |
C31H30N8O4 |
 |
1-Pyrrolidinecarboxylic acid, 4-oxo-2-(3-thiazolidinylcarbonyl)-, 1,1-diMethylethyl ester, (2R)- |
1415908-67-6 |
C13H20N2O4S |
![(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(phenyl)Morpholine hydrochloride](/CAS/20150408/GIF/874460-46-5.gif) |
(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(phenyl)Morpholine hydrochloride |
874460-46-5 |
C20H20ClF6NO2 |
 |
AlMotriptan iMpurity |
|
|
 |
AlMotriptan iMpurity |
|
|
 |
FaMotidine iMpurity |
130463-35-3 |
C5H8N4S2.Na |
 |
Nitrendipine iMpurity |
|
|
 |
TraMadol EP IMpurity-C |
66170-31-8 |
C16H24ClNO |
 |
Anastrozole IMpurity (3-(1-Cyano-1-Methylethyl)-alfa,alfa-diMethyl-5-(1H-,1,2,4-triazole-1-ylMethyl)-benzeneacetic acid) |
1338800-82-0 |
C17H20N4O2 |
 |
Anastrozole IMpurity (3-(1-Cyano-1-Methylethyl)-alfa,alfa-diMethyl-5-(1H-,1,2,4-triazole-1-ylMethyl)-benzeneacetic acid) |
1338800-82-0 |
C17H20N4O2 |
 |
AtracuriuM IMpurity K (Mixture of cis, trans, cis, cis(K1 & K2), tans, trans IsoMer) |
|
|
 |
ChlorphenaMine IMpurity B |
|
|
 |
Clozapine EP IMpurity D |
65514-71-8 |
C18H21ClN4O |
 |
Febuxostat IMpurity (2-(3-carboxy-4-isobutyloxyphenyl)-4-Methylthiazole-5-carboxylic acid) |
|
|
 |
Fluconazole IMpurity I |
|
C13H12F2N6O |
 |
IMidafenacin Related CoMpound 1 (4-(1H-IMidzol-1-yl)-2,2-DiphenylbutanaMide) |
170105-20-1 |
C19H19N3O |
 |
IMidafenacin Related CoMpound 6 (4-AcetiMidoylaMino-2,2-DiphenylbutanaMide) |
503598-33-2 |
C18H21N3O |
 |
Lansoprazole IMpurity H |
1346598-28-4 |
C23H16F3N5OS |
 |
LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl) |
1933471-30-7 |
C8H14N2O3 |
 |
Milrinone IMpurity 4 |
|
|
 |
Nebivolol O-Beta-D-Glucuronide |
1698091-61-0 |
C22H27NO4 |
 |
Nicergoline IMp. C (EP) |
|
|
 |
Perindopril IMpurity E |
|
|
 |
Pitavastatin 3-Oxo SodiuM |
2245811-12-3 |
C25H22FNO4 |
 |
PraMipexole IMp.BI-II828BS |
|
C20H32N6S2 |
 |
Propofol IMpurity F |
|
|
 |
Sertraline IMpurity (SRTRC-3) |
91797-76-1 |
C17H17Cl2N |
 |
Terbutaline IMpurity B |
94120-05-5 |
C13H19NO3 |
![Benzoic acid, 4-[(4-Methyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)-](/CAS/20150408/GIF/859282-11-4.gif) |
Benzoic acid, 4-[(4-Methyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)- |
859282-11-4 |
C14H17F3N2O2 |
 |
5-chloro-2,3-diphenylpyrazine |
41270-66-0 |
C16H11ClN2 |
 |
Canagliflozin iMpurity |
2648347-42-4 |
|
 |
Vortioxetine iMpurity |
853745-55-8 |
C10H14BrClN2 |
 |
PD 312236 |
501666-24-6 |
C20H35NO11 |
![(17α)-3,3-[1,2-Ethanediylbis(oxy)]-17-hydroxy-19-norpregna-5(10),9(11)-diene-21-nitrile](/CAS/GIF/190662-30-7.gif) |
(17α)-3,3-[1,2-Ethanediylbis(oxy)]-17-hydroxy-19-norpregna-5(10),9(11)-diene-21-nitrile |
190662-30-7 |
C22H29NO3 |
 |
(S)-4-(4-Hydrazinobenzyl)-2-oxazolidinone Hydrochloride |
139264-57-6 |
C10H14ClN3O2 |